clinical trial · NCT02933827
Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease
UnicoCell Biomed CO. LTD·phase2·completed·n = 39
Moderate to Severe Chronic Kidney DiseaseELIXCYTE
brief summary
1. To assess the safety of allogeneic injection of expanded ADSCs to patients with Moderate to Severe Chronic Kidney Disease 2. To assess the efficacy of allogeneic injection of expanded ADSCs to patients with Moderate to Severe Chronic Kidney Disease
started
May 1, 2018
primary completion
Apr 23, 2019
completion
Jun 21, 2023
last updated
Feb 9, 2024
official title
A Phase I/II Study to Evaluate the Safety and Efficacy of Allogeneic Infusion of Adipose-Derived Stem Cells in Moderate to Severe Chronic Kidney Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol